MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

Impact · against what's priced in

MDXG shares face a conflicting set of updates: record 2025 performance and a $100 million buyback program are countered by a revenue decline forecast for 2026. The estimated 2026 sales range of $340-360 million is a notable drop from 2025's $419 million, driven by Medicare reimbursement headwinds.

MDXG+0.20: No priced-in read yet

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

What matters in this story

Celanese Corporation (CE) Q3 2026 Earnings Call Transcript

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

What matters in this story

Celanese Corporation (CE) Q3 2026 Earnings Call Transcript

How each ticker is affected

Track these names every morning.

DigitalOcean: 3 Key Takeaways for Long-Term Investors

Broadridge: 3 Key Takeaways for Long-Term Investors

KB Home (KBH) Stock Sinks As Market Gains: Here's Why

Monday.com (MNDY) Stock Slides as Market Rises: Facts to Know Before You Trade

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

What matters in this story

Next reads from the same story arc

Celanese Corporation (CE) Q3 2026 Earnings Call Transcript

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results

What matters in this story

Next reads from the same story arc

Celanese Corporation (CE) Q3 2026 Earnings Call Transcript

How each ticker is affected

Track these names every morning.

DigitalOcean: 3 Key Takeaways for Long-Term Investors

Broadridge: 3 Key Takeaways for Long-Term Investors

KB Home (KBH) Stock Sinks As Market Gains: Here's Why

Monday.com (MNDY) Stock Slides as Market Rises: Facts to Know Before You Trade